Department of Microbiology and Physiological Systems; Department of Medicine, Division of Infectious Diseases and Immunology; Department of Biochemistry and Molecular Pharmacology; Program in Bioinformatics and Integrative Biology
Ecology and Evolutionary Biology | Genetic Phenomena | Immunology and Infectious Disease | Pharmaceutical Preparations | Therapeutics | Viruses
The rapid evolution of drug resistance remains a critical public health concern. The treatment of influenza A virus (IAV) has proven particularly challenging, due to the ability of the virus to develop resistance against current antivirals and vaccines. Here we evaluate a novel antiviral drug therapy, favipiravir, for which the mechanism of action in IAV involves an interaction with the viral RNA- dependent RNA polymerase resulting in an effective increase in the viral mutation rate. We utilize an experimental evolution framework, combined with novel population genetic method development for inference from time-sampled data, in order to evaluate the effectiveness of favipiravir against IAV. Evaluating whole genome polymorphism data across fifteen time points under multiple drug concentrations and in controls, we present the first evidence for the ability of viral populations to effectively adapt to low concentrations of favipiravir. In contrast, under high concentrations, we observe population extinction, indicative of mutational meltdown. We discuss the observed dynamics with respect to the evolutionary forces at play and emphasize the utility of evolutionary theory to inform drug development.
evolutionary biology, influenza A virus. drug resistance, favipiravir, RNA, antiviral drugs, mutational meltdown
Rights and Permissions
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY-NC-ND 4.0 International license.
DOI of Published Version
bioRxiv 048934; doi: https://doi.org/10.1101/048934. Link to preprint on bioRxiv service.
Now published in Evolution doi: 10.1111/evo.13041
Bank C, Renzette N, Liu P, Matuszewski S, Shim H, Foll M, Bolon DN, Zeldovich KB, Kowalik TF, Finberg RW, Wang JP, Jensen JD. (2016). An experimental evaluation of drug-induced mutational meltdown as an antiviral treatment strategy. University of Massachusetts Medical School Faculty Publications. https://doi.org/10.1101/048934. Retrieved from https://escholarship.umassmed.edu/faculty_pubs/1539
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.